← Explore

Preventive Effect of Low Intensity Pulsed Ultrasound against Experimental Cerebral Ischemia/Reperfusion Injury via Apoptosis Reduction and Brain-derived Neurotrophic Factor Induction

Chang-Mu Chen, Cheng-Tien Wu, Ting-Hua Yang, Shing-Hwa Liu, Feng-Yi Yang

Scientific Reports 2018 · 10.1038/s41598-018-23929-8

rodentin vitro cellstrokebehaviourhistology molecular

Abstract

Stroke is known as the top 10 causes of death worldwide. Development of effectively neuroprotective or preventive strategies for ischemia stroke is imperative. For the purpose of stroke prevention, we tested the neuroprotective effects of low-intensity pulsed ultrasound (LIPUS) on ischemic stroke. Adult C57BL/6 mice were used to daily treatment with LIPUS for 5 days on left hemisphere before middle cerebral artery occlusion (MCAO)-induced cerebral ischemia/reperfusion injury. Western blotting and immunohistochemistry were performed to assess the protein expressions of signaling molecules. Pretreatment with LIPUS significantly ameliorated the brain ischemic damage, including the reduction of neurological deficit score, infarct area, histopathological score, and showed a better performance in neurological and behavior functions. LIPUS pretreatment could also significantly decrease the neuronal cell apoptosis and upregulation of apoptosis-related signaling molecules and downregulation of brain-derived neurotrophic factor (BDNF) in brain tissues of MCAO-treated mice. Furthermore, LIPUS significantly prevented the decreased cell viability, the increased caspase-3 cleavage, and the decreased BDNF expression in ischemia/reperfusion-treated microglial cells. These results demonstrate that LIPUS effectively prevented the cerebral ischemia/reperfusion injury through apoptosis reduction and BDNF induction in a MCAO mouse model. The neuroprotective potential of LIPUS may provide a novel preventive strategy for ischemic stroke in high-risk patients.

Abstract via europepmc.

Speciesmouse (C57BL/6)
Subjects6 animals
Sessions per subject5
Randomisednot reported
Blindingnot reported
Sham / controlno treatment control
Auditory controlnot reported
Readout timingoffline
Anaesthesiaboth
Readoutsbehaviour, histology molecular — Neurological deficit score; rotarod; locomotor activity; TTC infarct volume; H&E; TUNEL; caspase-3 activity; Western blot (Bax, Bcl-2, VEGF, BDNF); BDNF immunohistochemistry; MTT cell viability
Direction of effectmixed or unclearLIPUS pretreatment reduced MCAO-induced deficits, infarct, apoptosis markers and the MCAO-induced fall in BDNF; excitation or inhibition was not assessed.
Adverse eventsnot reported

Exposures

Exposure 1: LIPUS pretreatment, mouse left hemisphere

Target: cerebral cortex — “the target region in the injured cortical areas”
Device: Olympus / Panametrics · Panametrics · A392S ✓

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)1,000✓✓✓
Pulse duration (ms)not reportedimplied by duty cycle ÷ PRF: 50 ms (not stated by the paper)⚑
Pulse repetition frequency (Hz)1✓✓✓
Duty cycle (%)5✓✓✓
Sonication duration (s)not reported⚑
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Ispta, domain unspecified (W/cm²)0.528✓✓✓⚑
Protocol, in the paper’s words

1.0 MHz focused transducer, 5% duty cycle, repetition frequency 1 Hz; acoustic power 0.51 W; 15 min daily (a 5-minute interval between each sonication) for 5 days before MCAO.

Exposure 2: LIPUS pretreatment of BV-2 microglial cells before hypoxia/reperfusion

Target: cultured glia — “BV2 cells”
Device: not reported

Pulse timing
Waveformnot reported
Fundamental frequency (kHz)not reported⚑
Pulse duration (ms)not reported
Pulse repetition frequency (Hz)not reported
Duty cycle (%)not reported
Sonication duration (s)900✓✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot applicable
In-situ pressure (kPa)not applicable
In-situ Isppa (W/cm²)not applicable
In-situ Ispta (W/cm²)not applicable
Ispta, domain unspecified (W/cm²)0.11✓✓✓
Protocol, in the paper’s words

BV2 cells were pre-treated with LIPUS for 15 min (intensity 110 mW/cm2) before hypoxia (6 h) and reperfusion (12 h).

Flags from extraction

  • n_subjects — Only n = 6 per group is given (Western blot n = 3-5); recorded the LIPUS group size. No total stated.
  • exposures[0].timing.sonication_duration_s — 15 min daily with a 5-minute interval between each sonication; the length of one uninterrupted sonication is unclear, 900 s is the daily total.
  • exposures[0].unspecified_domain.ispta_w_cm2 — 528 mW/cm2 converted to 0.528 W/cm2; domain not stated.
  • exposures[1].fundamental_frequency_khz — Frequency for the cell exposure is not stated; paper says only LIPUS 110 mW/cm2 for 15 min.
  • exposures[0].timing.pulse_duration_ms — Pulse duration not stated; paper gives duty cycle 5% and 1 Hz only.
  • exposures[0].device.family — Panametrics A392S transducer mapped to olympus_panametrics.